Evaluating the costs of adverse drug events in hospitalized patients: a systematic review

Abstract Background Adverse drug events (ADEs) are not only a safety and quality of care issue for patients, but also an economic issue with significant costs. Because they often occur during hospital stays, it is necessary to accurately quantify the costs of ADEs. This review aimed to investigate t...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Maxime Durand, Christel Castelli, Clarisse Roux-Marson, Jean-Marie Kinowski, Géraldine Leguelinel-Blache
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	BMC 2024-02-01
Edice:	Health Economics Review
Témata:	Systematic review Adverse drug events Costs Health economics Pharmacovigilance
On-line přístup:	https://doi.org/10.1186/s13561-024-00481-y
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!